myopia treatment market trends, myopia treatment market insights, myopia treatment market demand, myopia treatment market growth, myopia treatment market research, myopia treatment market analysis
How has the myopia treatment market evolved, and where is it heading next?
The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to an increase in the geriatric population, increasing government awareness programs, increasing awareness of myopia treatment, increasing investment in research and development, and rising incidence of distance vision impairment.
The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $28.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the increasing occurrence of distance vision impairment, increasing use of digital channels, rising healthcare infrastructure, rising incidence of myopia, and increasing cases of vision loss. Major trends in the forecast period include the adoption of rigid gas-permeable contact lenses, advancement in light-based therapies, cutting-edge research investigating the genetic factors, the adoption of digital platforms and apps, and development in atropine eye drops.
Get Your Free Sample of The Global Myopia Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20892&type=smp
What are the key drivers behind the rapid expansion of the myopia treatment market?
The increase in screen time is expected to propel the growth of the myopia treatment market going forward. Screen time refers to the time a person spends using devices with screens, such as smartphones, tablets, computers, or televisions. The increase in screen time is due to the rise in streaming services, social media usage, remote work, and virtual meetings. Myopia treatment helps reduce eye strain and discomfort from prolonged screen time, improving focus and comfort and enhancing visual clarity. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, between July 2021 and December 2023, 50.4% of teenagers aged 12–17 spent 4 or more hours per day on screens, while 22.8% had 3 hours, 17.8% had 2 hours, 6.1% had 1 hour, and 3.0% spent less than 1 hour daily on screens. Therefore, the increase in screen time is driving the growth of the myopia treatment market.
What is the segmentation for the myopia treatment market?
The myopia treatment market covered in this report is segmented –
1) By Type: Simple Myopia, High Myopia, Pathological Myopia
2) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K)
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels
5) By End-User: Hospital Or Clinical Laboratories, Physician Offices, Reference Laboratories, Other End-Users
Subsegments:
1) By Simple Myopia: Mild Myopia, Moderate Myopia
2) By High Myopia: Severe Myopia, Very Severe Myopia
3) By Pathological Myopia: Degenerative Myopia, Malignant Myopia
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/myopia-treatment-global-market-report
Who are the most influential companies in the myopia treatment market?
Major companies operating in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.
What are the most influential trends expected to drive the myopia treatment market forward?
Major companies operating in the myopia treatment market are focusing on developing advanced products such as optical biometers to enhance diagnostic precision and tailor effective, individualized treatments. Optical biometers use light to measure eye parameters, such as axial length and corneal curvature, to diagnose and monitor eye conditions. For instance, in February 2023, NIDEK Co., Ltd., a Japan-based manufacturer of ophthalmic products, launched an AL-Scan M and MV-1. This AL-Scan M device incorporates 3D auto-tracking and auto-shot functions, enabling efficient and user-friendly measurements similar to an autorefractor’s. These features improve patient throughput, particularly for younger patients. The AL-Scan M is precisely engineered to provide precise axial length measurements, a critical factor in monitoring myopia progression. Additionally, it seamlessly integrates with the MV-1 Myopia Viewer software, which helps track treatment history and patient behavior.
What are the major regional insights for the myopia treatment market, and which region holds the top position?
Asia Pacific was the largest region in the myopia treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Myopia Treatment Market Report 2025 Offer?
The myopia treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Myopia treatment refers to medical or corrective interventions used to manage or correct myopia, also known as nearsightedness. Myopia is a common refractive error of the eye where distant objects appear blurry, but close objects are clear. Myopia treatment’s main goal is to improve vision and quality of life by correcting refractive errors. It also helps manage myopia progression, reducing reliance on corrective lenses for long-term vision health.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20892
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
